Importance of updating family cancer history in childhood cancer survivors - Selena Russo; Meera Warby; Katherine M. Tucker; Claire E. Wakefield; Richard J. Cohn (Familial Cancer, 2017)

Universal screening for microsatellite instability in colorectal cancer in the clinical genomics era: new recommendations, methods, and considerations - Jaclyn F. Hechtman; Sumit Middha; Zsofia K. Stadler; Ahmet Zehir; Michael F. Berger; Efsevia Vakiani; Martin R. Weiser; Marc Ladanyi; Leonard B. Saltz; David S. Klimstra; Jinru Shia (Familial Cancer, 2017)

A Peutz–Jeghers syndrome family associated with sinonasal adenocarcinoma: 28 years follow up report - Jy-Ming Chiang; Tse-Ching Chen (Familial Cancer, 2017)

Genetic polymorphisms of NFκB1-94ins/delATTG and NFκBIA-881A/G genes in Egyptian patients with colorectal cancer - Mohamed Ragab Youssef; Zeinab Ibraheim Attia; Rizk Ahmed El-Baz; Sameh Roshdy; Ahmad Settin (Familial Cancer, 2017)

A new POT1 germline mutation—expanding the spectrum of POT1-associated cancers - Tremika Le-Shan Wilson; Namita Hattangady; Antonio Marcondes Lerario; Carmen Williams; Erika Koeppe; Shane Quinonez; Jenae Osborne; Kelly B. Cha; Tobias Else (Familial Cancer, 2017)

Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population - Syeda Hafiza Benish Ali; Kashif Sardar Bangash; Abdur Rauf; Muhammad Younis; Khursheed Anwar; Raja Khurram; Muhammad Athar Khawaja; Maleeha Azam; Abid Ali Qureshi; Saeed Akhter; Lambertus A. Kiemeney; Raheel Qamar (Familial Cancer, 2017)

All in the family? Communication of cancer survivors with their families - Deborah J. Bowen; Jennifer L. Hay; Julie N. Harris-Wai; Hendrika Meischke; Wylie Burke (Familial Cancer, 2017)

A case of contralateral breast cancer and skin cancer associated with NBN heterozygous pathogenic variant c.698_701delAACA - Jennifer Gass; Jessica Jackson; Sarah Macklin; Patrick Blackburn; Stephanie Hines; Paldeep S. Atwal (Familial Cancer, 2017)

Elucidating the clinical significance of two PMS2 missense variants coexisting in a family fulfilling hereditary cancer criteria - Maribel González-Acosta; Jesús del Valle; Matilde Navarro; Bryony A. Thompson; Sílvia Iglesias; Xavier Sanjuan; María José Paúles; Natàlia Padilla; Anna Fernández; Raquel Cuesta; Àlex Teulé; Guido Plotz; et al. (Familial Cancer, 2017)

Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers - Sumati Gupta; Samantha Greenberg; Jade Grimmett; David Gaston; Neeraj Agarwal; William Lowrance; Joshua Schiffman; Wendy Kohlmann (Familial Cancer, 2017)

Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine - I. Gorodetska; S. Serga; T. Lahuta; L. Ostapchenko; S. Demydov; N. Khranovska; O. Skachkova; M. Inomistova; O. Kolesnik; V. Svintsitsky; N. Tsip; A. Peresunko; et al. (Familial Cancer, 2017)

Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer - Y. C. Lee; M. Bressel; P. Grant; P. Russell; C. Smith; S. Picken; S. Camm; B. E. Kiely; R. L. Milne; S. A. McLachlan; M. Hickey; M. L. Friedlander; et al. (Familial Cancer, 2017)

Lower gastrointestinal neuroendocrine neoplasms associated with hereditary cancer syndromes: a case series - Trilokesh D. Kidambi; Christina Pedley; Amie Blanco; Emily K. Bergsland; Jonathan P. Terdiman (Familial Cancer, 2017)

High-risk individuals’ perceptions of reproductive genetic testing for CDH1 mutations - Nina Hallowell; Shirlene Badger; Sue Richardson; Carlos Caldas; Richard H. Hardwick; Rebecca C. Fitzgerald; Julia Lawton (Familial Cancer, 2017)

Supporting disclosure of genetic information to family members: professional practice and timelines in cancer genetics - Benjamin Derbez; Antoine de Pauw; Dominique Stoppa-Lyonnet; Sandrine de Montgolfier (Familial Cancer, 2017)

Gastric tumours in FAP - Sarah-Jane Walton; Ian M. Frayling; Susan K. Clark; Andrew Latchford (Familial Cancer, 2017)

Patients with negative multi-gene panel testing: a back to the future paradox? - Steven M. Sorscher (Familial Cancer, 2017)

Biallelic BRCA2 mutations in two black South African children with Fanconi anaemia - Candice Feben; Careni Spencer; Anneline Lochan; Nakita Laing; Karen Fieggen; Engela Honey; Tasha Wainstein; Amanda Krause (Familial Cancer, 2017)

Gastric cancer in FAP: a concerning rise in incidence - Gautam Mankaney; Pamela Leone; Michael Cruise; Lisa LaGuardia; Margaret O’Malley; Amit Bhatt; James Church; Carol A. Burke (Familial Cancer, 2017)

A lesson from a reported pathogenic variant in Peutz-Jeghers syndrome: a case report - Hu Tan; Xianda Wei; Pu Yang; Yanru Huang; Haoxian Li; Desheng Liang; Lingqian Wu (Familial Cancer, 2017)

The association between prognosis of breast cancer and first-degree family history of breast or ovarian cancer: a systematic review and meta-analysis - Jun-Long Song; Chuang Chen; Jing-Ping Yuan; Sheng-Rong Sun (Familial Cancer, 2017)

Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives - Jessica Ezzell Hunter; Kathleen A. Arnold; Jennifer E. Cook; Jamilyn Zepp; Marian J. Gilmore; Alan F. Rope; James V. Davis; Kellene M. Bergen; Elizabeth Esterberg; Kristin R. Muessig; Susan K. Peterson; Sapna Syngal; et al. (Familial Cancer, 2017)

Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens - Mohammad R. Akbari; Shiyu Zhang; Deborah Cragun; Ji-Hyun Lee; Domenico Coppola; John McLaughlin; Harvey A. Risch; Barry Rosen; Patricia Shaw; Thomas A. Sellers; Joellen Schildkraut; Steven A. Narod; et al. (Familial Cancer, 2017)

Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? - Kate A. McBride; Mandy L. Ballinger; Timothy E. Schlub; Mary-Anne Young; Martin H. N. Tattersall; Judy Kirk; Ros Eeles; Emma Killick; Leslie G. Walker; Sue Shanley; David M. Thomas; Gillian Mitchell (Familial Cancer, 2017)

Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls - Sibel Saya; Emma Killick; Sarah Thomas; Natalie Taylor; Elizabeth K. Bancroft; Jeanette Rothwell; Sarah Benafif; Alexander Dias; Christos Mikropoulos; Jenny Pope; Anthony Chamberlain; Ranga Gunapala; et al. (Familial Cancer, 2017)

Mutation screening of ACKR3 and COPS8 in kidney cancer cases from the CONFIRM study - Maryam Mahmoodi; Tu Nguyen-Dumont; Fleur Hammet; Bernard J. Pope; Daniel J. Park; Melissa C. Southey; John M. Darlow; Fiona Bruinsma; Ingrid Winship (Familial Cancer, 2017)

Novel and reported pathogenic variants in exon 11 of BRCA2 gene in a cohort of Sri Lankan young breast cancer patients - Sumadee De Silva; Kamani Hemamala Tennekoon; Aravinda Dissanayake; Kanishka De Silva; Lakshika Jayasekara (Familial Cancer, 2017)

Identification of MSH2 inversion of exons 1–7 in clinical evaluation of families with suspected Lynch syndrome - Maureen E. Mork; Andrea Rodriguez; Melissa W. Taggart; Miguel A. Rodriguez-Bigas; Patrick M. Lynch; Sarah A. Bannon; Y. Nancy You; Eduardo Vilar (Familial Cancer, 2017)

ATM mutations for surgeons - Sara A. Mansfield; Robert Pilarski; Doreen M. Agnese (Familial Cancer, 2017)

Embryonal rhabdomyosarcoma in a patient with a heterozygous frameshift variant in the DICER1 gene and additional manifestations of the DICER1 syndrome - Julia Fremerey; Stefan Balzer; Triantafyllia Brozou; Joerg Schaper; Arndt Borkhardt; Michaela Kuhlen (Familial Cancer, 2017)

Outcomes of retesting BRCA negative patients using multigene panels - Siddhartha Yadav; Ashley Reeves; Sarah Campian; Amy Paine; Dana Zakalik (Familial Cancer, 2017)

The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases - Leora Witkowski; Nancy Donini; Rebecca Byler-Dann; James A. Knost; Steffen Albrecht; Andrew Berchuck; W. Glenn McCluggage; Martin Hasselblatt; William D. Foulkes (Familial Cancer, 2017)

Detection of false positive mutations in BRCA gene by next generation sequencing - Moushumi Suryavanshi; Dushyant Kumar; Manoj Kumar Panigrahi; Meenakshi Chowdhary; Anurag Mehta (Familial Cancer, 2017)

Identification of a rare germline NBN gene mutation by whole exome sequencing in a lung-cancer survivor from a large family with various types of cancer - Makia J. Marafie; Mohammed Dashti; Fahd Al-Mulla (Familial Cancer, 2017)

Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer - Martin P. Nilsson; Christof Winter; Ulf Kristoffersson; Martin Rehn; Christer Larsson; Lao H. Saal; Niklas Loman (Familial Cancer, 2017)

Four generations of SDHB-related disease: complexities in management - U. Srirangalingam; M. LeCain; N. Tufton; S. A. Akker; W. M. Drake; K. Metcalfe (Familial Cancer, 2017)

Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome - Eva Wielders; Elly Delzenne-Goette; Rob Dekker; Martin van der Valk; Hein te Riele (Familial Cancer, 2017)

Recurrent TP53 missense mutation in cancer patients of Arab descent - Aviad Zick; Luna Kadouri; Sherri Cohen; Michael Frohlinger; Tamar Hamburger; Naama Zvi; Morasha Plaser; Eilat Avital; Shani Breuier; Firase Elian; Azzam Salah; Yael Goldberg; et al. (Familial Cancer, 2017)

All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients - Kristin L. Long; Carol Etzel; Thereasa Rich; Samuel Hyde; Nancy D. Perrier; Paul H. Graham; Jeffrey E. Lee; Mimi I. Hu; Gilbert J. Cote; Robert Gagel; Elizabeth G. Grubbs (Familial Cancer, 2017)

Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor - Caroline Goehringer; Christian Sutter; Matthias Kloor; Johannes Gebert; Emily P. Slater; Monika Keller; Irmgard Treiber; Petra Ganschow; Martina Kadmon; Ute Moog (Familial Cancer, 2017)

Cancer screening behaviors and risk perceptions among family members of colorectal cancer patients with unexplained mismatch repair deficiency - Lior H. Katz; Shailesh Advani; Allison M. Burton-Chase; Bryan Fellman; Katrina M. Polivka; Ying Yuan; Patrick M. Lynch; Susan K. Peterson (Familial Cancer, 2017)

Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe - Natalia Bogdanova; Katja Pfeifer; Peter Schürmann; Natalia Antonenkova; Wulf Siggelkow; Hans Christiansen; Peter Hillemanns; Tjoung-Won Park-Simon; Thilo Dörk (Familial Cancer, 2017)

Colonoscopy in Lynch syndrome: the need for a new quality score - Jurjen J. Boonstra; Wouter H. de Vos tot Nederveen Cappel; Alexandra M. J. Langers; Hedwig van der Sluis; James H. Hardwick; Hans F. A. Vasen (Familial Cancer, 2017)

DICER1 mutation and tumors associated with a familial tumor predisposition syndrome: practical considerations - Eduardo J. Bardón-Cancho; Ana Haro-Díaz; Francisco J. Alonso-García-de la Rosa; Jorge Huerta-Aragonés; Marina García-Morín; Felipe González-Martínez; Carmen Garrido-Colino (Familial Cancer, 2017)

Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands - Charlotte J. Dommering; Lidewij Henneman; Annemarie H. van der Hout; Marianne A. Jonker; Carli M. J. Tops; Ans M. W. van den Ouweland; Rob B. van der Luijt; Arjen R. Mensenkamp; Frans B. L. Hogervorst; Egbert J. W. Redeker; Christine E. M. de Die-Smulders; Annette C. Moll; et al. (Familial Cancer, 2017)

Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway - Trine Levin; Lovise Mæhle (Familial Cancer, 2017)

Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores - D. G. Evans; E. R. Woodward; S. J. Howell; S. Verhoef; A. Howell; F. Lalloo (Familial Cancer, 2017)

Pain evaluation during gynaecological surveillance in women with Lynch syndrome - Jorien Helder-Woolderink; Geertruida de Bock; Harry Hollema; Magda van Oven; Marian Mourits (Familial Cancer, 2017)

Attenuated polyposis of the large bowel: a morphologic and molecular approach - Maurizio Ponz de Leon; Monica Pedroni; Luca Roncucci; Federica Domati; Giuseppina Rossi; Giulia Magnani; Annalisa Pezzi; Rossella Fante; Luca Reggiani Bonetti (Familial Cancer, 2017)

BRCA1 allele-specific expression in genetic predisposed breast/ovarian cancer - Estelle Jamard; Bertrand Volard; Audrey Emmanuelle Dugué; Angelina Legros; Alexandra Leconte; Bénédicte Clarisse; Grégoire Davy; Florence Polycarpe; Catherine Dugast; Caroline Abadie; Thierry Frebourg; Julie Tinat; et al. (Familial Cancer, 2017)

A case of multiple gastrointestinal stromal tumors caused by a germline KIT gene mutation (p.Leu576Pro) - Rita Vale Rodrigues; Filipa Santos; João Pereira da Silva; Inês Francisco; Isabel Claro; Cristina Albuquerque; Maria Manuel Lemos; Manuel Limbert; António Dias Pereira (Familial Cancer, 2017)

Cystic parathyroid glands in MEN1: A rare entity? - Tiziana Cavalli; Francesco Giudici; Gabriella Nesi; Andrea Amorosi; Raffaella Santi; Maria Luisa Brandi; Francesco Tonelli (Familial Cancer, 2017)

TP53 and CDKN1A mutation analysis in families with Li–Fraumeni and Li–Fraumeni like syndromes - Raissa Coelho Andrade; Anna Claudia Evangelista dos Santos; Joaquim Caetano de Aguirre Neto; Julián Nevado; Pablo Lapunzina; Fernando Regla Vargas (Familial Cancer, 2017)

Expanding the genotype–phenotype spectrum in hereditary colorectal cancer by gene panel testing - Anna Rohlin; Eva Rambech; Anders Kvist; Therese Törngren; Frida Eiengård; Ulf Lundstam; Theofanis Zagoras; Samuel Gebre-Medhin; Åke Borg; Jan Björk; Mef Nilbert; Margareta Nordling (Familial Cancer, 2017)

Genetically diagnosed Birt–Hogg–Dubé syndrome and familial cerebral cavernous malformations in the same individual: a case report - James Whitworth; Brian Stausbøl-Grøn; Anne-Bine Skytte (Familial Cancer, 2017)

Exploring clinicians’ attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer - Yanni Chen; Michelle Peate; Rajneesh Kaur; Bettina Meiser; Tim Wong; Judy Kirk; Robyn L. Ward; Annabel Goodwin; Finlay Macrae; Janet Hiller; Alison H. Trainer; Gillian Mitchell (Familial Cancer, 2017)

Pancreas-sparing total duodenectomy for Spigelman stage IV duodenal polyposis associated with familial adenomatous polyposis: experience of 10 cases at a single institution - Yuichiro Watanabe; Hideyuki Ishida; Hiroyuki Baba; Takeo Iwama; Atsushi Kudo; Minoru Tanabe; Hideki Ishikawa (Familial Cancer, 2017)

Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance - Ingrid C.A.W. Konings; Femme Harinck; Marianne A. Kuenen; Grace N. Sidharta; Jacobien M. Kieffer; Cora M. Aalfs; Jan-Werner Poley; Ellen M.A. Smets; Anja Wagner; Anja van Rens; Frank P. Vleggaar; Margreet G.E.M. Ausems; et al. (Familial Cancer, 2017)

Hereditary breast and ovarian cancer: successful systematic implementation of a group approach to genetic counselling - Patrick R. Benusiglio; Marina Di Maria; Leila Dorling; Anne Jouinot; Antoine Poli; Sophie Villebasse; Marine Le Mentec; Béatrice Claret; Diane Boinon; Olivier Caron (Familial Cancer, 2017)

Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases - Walid Sabri Hamadou; Sawsen Besbes; Violaine Bourdon; Yosra Ben Youssef; Mohamed Adnène Laatiri; Testsuro Noguchi; Abderrahim Khélif; Hagay Sobol; Zohra Soua (Familial Cancer, 2017)

Frequency of germline PALB2 mutations among women with epithelial ovarian cancer - Joanne Kotsopoulos; Victoria Sopik; Barry Rosen; Isabel Fan; John R. McLaughlin; Harvey Risch; Ping Sun; Steven A. Narod; Mohammad R. Akbari (Familial Cancer, 2017)

Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer - Afaf Elsaid; Rami Elshazli; Fatma El-Tarapely; Hossam Darwish; Camelia Abdel-Malak (Familial Cancer, 2017)

Performance of Lynch syndrome predictive models in quantifying the likelihood of germline mutations in patients with abnormal MLH1 immunoexpression - Verónica Cabreira; Carla Pinto; Manuela Pinheiro; Paula Lopes; Ana Peixoto; Catarina Santos; Isabel Veiga; Patrícia Rocha; Pedro Pinto; Rui Henrique; Manuel R. Teixeira (Familial Cancer, 2017)

BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines - Danielle S. Chun; Brygida Berse; Vickie L. Venne; Scott L. DuVall; Kelly K. Filipski; Michael J. Kelley; Laurence J. Meyer; Michael S. Icardi; Julie A. Lynch (Familial Cancer, 2017)

A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency - Katharina Wimmer; Andreas Beilken; Rainer Nustede; Tim Ripperger; Britta Lamottke; Benno Ure; Diana Steinmann; Tanja Reineke-Plaass; Ulrich Lehmann; Johannes Zschocke; Laura Valle; Christine Fauth; et al. (Familial Cancer, 2017)

Calculating the optimal surveillance for head and neck paraganglioma in SDHB-mutation carriers - Karin Eijkelenkamp; Thamara E. Osinga; Mirjam M. de Jong; Wim J. Sluiter; Robin P. F. Dullaart; Thera P. Links; Michiel N. Kerstens; Anouk N. A. van der Horst-Schrivers (Familial Cancer, 2017)

Hereditary leiomyomatosis and renal cell cancer syndrome: identification and clinical characterization of a novel mutation in the FH gene in a Colombian family - Carolina Arenas Valencia; Martha Lucia Rodríguez López; Andrea Yimena Cardona Barreto; Edgar Garavito Rodríguez; Clara Eugenia Arteaga Díaz (Familial Cancer, 2017)

Nevoid basal cell carcinoma syndrome caused by splicing mutations in the PTCH1 gene - Chise Kato; Kentaro Fujii; Yuto Arai; Hiromi Hatsuse; Kazuaki Nagao; Yoshinaga Takayama; Kouzou Kameyama; Katsunori Fujii; Toshiyuki Miyashita (Familial Cancer, 2017)

Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing? - Geneviève Larouche; Jocelyne Chiquette; Sylvie Pelletier; Jacques Simard; Michel Dorval (Familial Cancer, 2017)

Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort - Elisabeth Jarhelle; Hilde Monica Frostad Riise Stensland; Lovise Mæhle; Marijke Van Ghelue (Familial Cancer, 2017)

Community attitudes towards a Jewish community BRCA1/2 testing program - Nicole Cousens; Rajneesh Kaur; Bettina Meiser; Lesley Andrews (Familial Cancer, 2017)

First description of mutational analysis of MLH1, MSH2 and MSH6 in Algerian families with suspected Lynch syndrome - H. Ziada-Bouchaar; K. Sifi; T. Filali; T. Hammada; D. Satta; N. Abadi (Familial Cancer, 2017)

Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer - Isaura S. Ibrahim; Bert A. Bonsing; Rutger-Jan Swijnenburg; Lieke Welling; Roeland A. Veenendaal; Martin N. J. M. Wasser; Hans Morreau; Akin Inderson; Hans F. A. Vasen (Familial Cancer, 2017)

Multi-gene panel testing for hereditary cancer susceptibility in a rural Familial Cancer Program - David J. Hermel; Wendy C. McKinnon; Marie E. Wood; Marc S. Greenblatt (Familial Cancer, 2017)

Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes - Sara E. Dobbins; Peter Broderick; Daniel Chubb; Ben Kinnersley; Amy L. Sherborne; Richard S. Houlston (Familial Cancer, 2016)

A model for patient-direct screening and referral for familial cancer risk - Kristin B. Niendorf; Melissa A. Geller; Rachel Isaksson Vogel; Timothy R. Church; Anna Leininger; Angela Bakke; Robert D. Madoff (Familial Cancer, 2016)

Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families - Janice P. Dutcher; Peter H. Wiernik; Leticia Varella; Rangaswamy Chintapatla (Familial Cancer, 2016)

An investigation of the factors effecting high-risk individuals’ decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC) - Nina Hallowell; Shirlene Badger; Sue Richardson; Carlos Caldas; Richard H. Hardwick; Rebecca C. Fitzgerald; Julia Lawton (Familial Cancer, 2016)

Angelina and Brad effect - Francois Eisinger (Familial Cancer, 2016)

Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families - Jazlyn Read; Judith Symmons; Jane M. Palmer; Grant W. Montgomery; Nicholas G. Martin; Nicholas K. Hayward (Familial Cancer, 2016)

Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome - Tiziana Cavalli; Francesco Giudici; Raffaella Santi; Gabriella Nesi; Maria Luisa Brandi; Francesco Tonelli (Familial Cancer, 2016)

Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency - Maureen E. Mork; Ester Borras; Melissa W. Taggart; Amanda Cuddy; Sarah A. Bannon; Y. Nancy You; Patrick M. Lynch; Pedro T. Ramirez; Miguel A. Rodriguez-Bigas; Eduardo Vilar (Familial Cancer, 2016)

MSI detection and its pitfalls in CMMRD syndrome in a family with a bi-allelic MLH1 mutation - Aurélia Nguyen; Gaelle Bougeard; Meriam Koob; Marie Pierre Chenard; Anne Schneider; Christine Maugard; Natacha Entz-Werle (Familial Cancer, 2016)

Patient and genetic counselor perceptions of in-person versus telephone genetic counseling for hereditary breast/ovarian cancer - Aryana S. Jacobs; Marc D. Schwartz; Heiddis Valdimarsdottir; Rachel H. Nusbaum; Gillian W. Hooker; Tiffani A. DeMarco; Jessica E. Heinzmann; Wendy McKinnon; Shelley R. McCormick; Claire Davis; Andrea D. Forman; Alexandra Perez Lebensohn; et al. (Familial Cancer, 2016)

CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome - Aysel Ahadova; Magnus von Knebel Doeberitz; Hendrik Bläker; Matthias Kloor (Familial Cancer, 2016)

Evaluation of TP53 Pro72Arg and MDM2 SNP285–SNP309 polymorphisms in an Italian cohort of LFS suggestive patients lacking identifiable TP53 germline mutations - Francesca Ponti; Serena Corsini; Maria Gnoli; Elena Pedrini; Marina Mordenti; Luca Sangiorgi (Familial Cancer, 2016)

No evidence of increased breast cancer risk for proven noncarriers from BRCA1 and BRCA2 families - Henriette Roed Nielsen; Janne Petersen; Lotte Krogh; Mef Nilbert; Anne-Bine Skytte (Familial Cancer, 2016)

Decentralized colonoscopic surveillance with high patient compliance prevents hereditary and familial colorectal cancer - Olle Sjöström; Lars Lindholm; Björn Tavelin; Beatrice Melin (Familial Cancer, 2016)

MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics - Jessica Oliboni Scapineli; Lucieli Ceolin; Márcia Khaled Puñales; José Miguel Dora; Ana Luiza Maia (Familial Cancer, 2016)

Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma - Roeliene C. Kruizinga; Denise M. S. van Marion; Wilfred F. A. den Dunnen; Jan C. de Groot; Eelco W. Hoving; Sjoukje F. Oosting; Hetty Timmer-Bosscha; Rosalie P. H. Derks; Chantal Cornelissen; Rob B. van der Luijt; Thera P. Links; Elisabeth G. E. de Vries; et al. (Familial Cancer, 2016)

Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India - Manjunath Goroshi; Tushar Bandgar; Anurag R. Lila; Swati Sachin Jadhav; Shruti Khare; Shailesh V. Shrikhande; Shinya Uchino; Abhay N. Dalvi; Nalini S. Shah (Familial Cancer, 2016)

Communicating genetic test results within the family: Is it lost in translation? A survey of relatives in the randomized six-step study - Mary B. Daly; Susan Montgomery; Ruth Bingler; Karen Ruth (Familial Cancer, 2016)

Colorectal cancer risk variants at 8q23.3 and 11q23.1 are associated with disease phenotype in APC mutation carriers - Z. Ghorbanoghli; M. H. Nieuwenhuis; J. J. Houwing-Duistermaat; S. Jagmohan-Changur; F. J. Hes; C. M. Tops; A. Wagner; C. M. Aalfs; S. Verhoef; E. B. Gómez García; R. H. Sijmons; F. H. Menko; et al. (Familial Cancer, 2016)

Evaluation of laboratory perspectives on hereditary cancer panels - Jessica Stoll; Scott M. Weissman; Nicole Hook; Christina Selkirk; Amy Knight Johnson; Anna Newlin; Kristen J. Vogel Postula (Familial Cancer, 2016)

Modeling the dyadic effects of parenting, stress, and coping on parent–child communication in families tested for hereditary breast-ovarian cancer risk - Jada G. Hamilton; Darren Mays; Tiffani DeMarco; Kenneth P. Tercyak (Familial Cancer, 2016)

Rapid detection of germline mutations for hereditary gastrointestinal polyposis/cancers using HaloPlex target enrichment and high-throughput sequencing technologies - Masakazu Kohda; Kensuke Kumamoto; Hidetaka Eguchi; Tomoko Hirata; Yuhki Tada; Kohji Tanakaya; Kiwamu Akagi; Seiichi Takenoshita; Takeo Iwama; Hideyuki Ishida; Yasushi Okazaki (Familial Cancer, 2016)

BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population - Henriette Roed Nielsen; Mef Nilbert; Janne Petersen; Steen Ladelund; Mads Thomassen; Inge Søkilde Pedersen; Thomas V. O. Hansen; Anne-Bine Skytte; Åke Borg; Christina Therkildsen (Familial Cancer, 2016)

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis - Renaud Sabatier; Elise Lavit; Jessica Moretta; Eric Lambaudie; Tetsuro Noguchi; François Eisinger; Elisabeth Cherau; Magali Provansal; Doriane Livon; Laetitia Rabayrol; Cornel Popovici; Emmanuelle Charaffe-Jauffret; et al. (Familial Cancer, 2016)

A mutation of the succinate dehydrogenase B gene in a Korean family with paraganglioma - Borum Sagong; Young Joon Seo; Hyun-Jin Lee; Mi Joo Kim; Un-Kyung Kim; In Seok Moon (Familial Cancer, 2016)

Introduction to special issue of Familial Cancer - Henry T. Lynch; Carrie L. Snyder (Familial Cancer, 2016)

Surgical considerations in FAP-related pouch surgery: Could we do better? - Gabriela Möslein (Familial Cancer, 2016)

Chemoprevention of familial adenomatous polyposis - Patrick M. Lynch (Familial Cancer, 2016)

Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate - Seth Septer; Caitlin E. Lawson; Shrikant Anant; Thomas Attard (Familial Cancer, 2016)

Recent discoveries in the molecular genetics of Lynch syndrome - C. Richard Boland (Familial Cancer, 2016)

Lynch syndrome in South America: past, present and future - Carlos A. Vaccaro; Carlos Sarroca; Benedito Rossi; Francisco Lopez-Kostner; Mev Dominguez; Natalia Causada Calo; Raul Cutait; Adriana Della Valle; Lina Nuñez; Florencia Neffa; Karin Alvarez; Maria Laura Gonzalez; et al. (Familial Cancer, 2016)

Hereditary cancer registries improve the care of patients with a genetic predisposition to cancer: contributions from the Dutch Lynch syndrome registry - Hans F. A. Vasen; Mary E. Velthuizen; Jan H. Kleibeuker; Fred H. Menko; Fokke M. Nagengast; Annemieke Cats; Andrea E. van der Meulen-de Jong; Martijn H. Breuning; Anne J. Roukema; Inge van Leeuwen-Cornelisse; Wouter H. de Vos tot Nederveen Cappel; Juul T. Wijnen (Familial Cancer, 2016)

Genetic counseling and cascade genetic testing in Lynch syndrome - Heather Hampel (Familial Cancer, 2016)

Estimating cumulative risks for breast cancer for carriers of variants in uncommon genes - Noralane M. Lindor; John Hopper; James Dowty (Familial Cancer, 2016)

Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications - Carrie Snyder (Familial Cancer, 2016)

Colonoscopy and chromoscopy in hereditary colorectal cancer syndromes - Erin Jenkins Wessling; Stephen J. Lanspa (Familial Cancer, 2016)

Familial atypical multiple mole melanoma (FAMMM) syndrome: history, genetics, and heterogeneity - Henry T. Lynch; Trudy G. Shaw (Familial Cancer, 2016)

Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation - Megan P. Hitchins (Familial Cancer, 2016)

High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine - Zoran Gatalica; Semir Vranic; Joanne Xiu; Jeffrey Swensen; Sandeep Reddy (Familial Cancer, 2016)

Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery - Murray Joseph Casey; Agnes B. Colanta (Familial Cancer, 2016)

Hereditary cancer syndromes: utilizing DNA repair deficiency as therapeutic target - Gaurav Goyal; Tiffany Fan; Peter Todd Silberstein (Familial Cancer, 2016)

Update on Lynch syndrome genomics - Päivi Peltomäki (Familial Cancer, 2016)

Controversies in the surgery of patients with familial adenomatous polyposis and Lynch syndrome - James M. Church (Familial Cancer, 2016)

Migrant breast cancer patients and their participation in genetic counseling: results from a registry-based study - J. E. Baars; A. M. van Dulmen; M. E. Velthuizen; E. B. M. Theunissen; B. C. Vrouenraets; A. N. Kimmings; T. van Dalen; B. van Ooijen; A. J. Witkamp; M. A. van der Aa; M. G. E. M. Ausems (Familial Cancer, 2016)

Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome - Trilokesh D. Kidambi; Amie Blanco; Jessica Van Ziffle; Jonathan P. Terdiman (Familial Cancer, 2016)

Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposis - Isabel Spier; Martin Kerick; Dmitriy Drichel; Sukanya Horpaopan; Janine Altmüller; Andreas Laner; Stefanie Holzapfel; Sophia Peters; Ronja Adam; Bixiao Zhao; Tim Becker; Richard P. Lifton; et al. (Familial Cancer, 2016)

CDH1 germline mutations and hereditary lobular breast cancer - Giovanni Corso; Mattia Intra; Chiara Trentin; Paolo Veronesi; Viviana Galimberti (Familial Cancer, 2016)

Developing and assessing the utility of a You-Tube based clinical genetics video channel for families affected by inherited tumours - G. E. Jones; J. H. Singletary; A. Cashmore; V. Jain; J. Abhulimhen; J. Chauhan; H. V. Musson; J. G. Barwell (Familial Cancer, 2016)

Germline BAP1 mutations misreported as somatic based on tumor-only testing - Mohamed H. Abdel-Rahman; Karan Rai; Robert Pilarski; Frederick H. Davidorf; Colleen M. Cebulla (Familial Cancer, 2016)

The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety - Erica Sermijn; Liesbeth Delesie; Ellen Deschepper; Ingrid Pauwels; Maryse Bonduelle; Erik Teugels; Jacques De Grève (Familial Cancer, 2016)

Relationship of immunohistochemistry, copy number aberrations and epigenetic disorders with BRCAness pattern in hereditary and sporadic breast cancer - Rosa Murria Estal; Sarai Palanca Suela; Inmaculada de Juan Jiménez; Cristina Alenda Gonzalez; Cecilia Egoavil Rojas; Zaida García-Casado; Jose Antonio López Guerrero; María José Juan Fita; Ana Beatriz Sánchez Heras; Ángel Segura Huerta; Ana Santaballa Bertrán; Isabel Chirivella González; et al. (Familial Cancer, 2016)

Initial clinical validation of Health Heritage, a patient-facing tool for personal and family history collection and cancer risk assessment - Leigh A. Baumgart; Kristen J. Vogel Postula; William A. Knaus (Familial Cancer, 2016)

Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect - Ingrid P. Vogelaar; Marjolijn J. L. Ligtenberg; Rachel S. van der Post; Richarda M. de Voer; C. Marleen Kets; Trees J. G. Jansen; Liesbeth Jacobs; Gerty Schreibelt; I. Jolanda M. de Vries; Mihai G. Netea; Nicoline Hoogerbrugge (Familial Cancer, 2016)

Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis - Nicolás Casellas-Cabrera; Yaritza Díaz-Algorri; Víctor J. Carlo-Chévere; María González-Pons; Natalia Rodríguez-Mañón; Julyann Pérez-Mayoral; Carlos Bertrán-Rodríguez; Marievelisse Soto-Salgado; Francis M. Giardiello; Segundo Rodríguez-Quilichini; Marcia Cruz-Correa (Familial Cancer, 2016)

Gatekeeper role of gastroenterologists and surgeons in recognising and discussing familial colorectal cancer - Kirsten F. L. Douma; Evelien Dekker; Ellen M. A. Smets; Cora M. Aalfs (Familial Cancer, 2016)

Mutation analysis of MUTYH in Japanese colorectal adenomatous polyposis patients - Keiko Taki; Yuri Sato; Sachio Nomura; Yuumi Ashihara; Mizuho Kita; Ikufumi Tajima; Kokichi Sugano; Masami Arai (Familial Cancer, 2016)

Determining the familial risk distribution of colorectal cancer: a data mining approach - Rowena Chau; Mark A. Jenkins; Daniel D. Buchanan; Driss Ait Ouakrim; Graham G. Giles; Graham Casey; Steven Gallinger; Robert W. Haile; Loic Le Marchand; Polly A. Newcomb; Noralane M. Lindor; John L. Hopper; et al. (Familial Cancer, 2016)

Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis - Sigurdis Haraldsdottir; Rachel Roth; Rachel Pearlman; Heather Hampel; Christina A. Arnold; Wendy L. Frankel (Familial Cancer, 2016)

Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1 - Bree Porcelli; Nancy L. Zoellner; Salmafatima S. Abadin; David H. Gutmann; Kimberly J. Johnson (Familial Cancer, 2016)

Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis - Eneida Santos de Oliveira; Bárbara Luisa Soares; Sara Lemos; Reginaldo Cruz Alves Rosa; Angélica Nogueira Rodrigues; Leandro Augusto Barbosa; Débora de Oliveira Lopes; Luciana Lara dos Santos (Familial Cancer, 2016)

Are lung cysts in renal cell cancer (RCC) patients an indication for FLCN mutation analysis? - Paul C. Johannesma; Arjan C. Houweling; Fred H. Menko; I. van de Beek; Rinze Reinhard; Johan J. P. Gille; JanHein T. M. van Waesberghe; Erik Thunnissen; Theo M. Starink; Pieter E. Postmus; R. Jeroen A. van Moorselaar (Familial Cancer, 2016)

Erratum to: Methylation of the miR-126 gene associated with glioma progression - Hongwei Cui; Yongping Mu; Lei Yu; Yaguang Xi; Rune Matthiesen; Xiulan Su; Wenjie Sun (Familial Cancer, 2016)

Non-genetic health professionals’ attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer - Kirsten F. L. Douma; Ellen M. A. Smets; Dawn C. Allain (Familial Cancer, 2016)

Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer - Nikoleta Poumpouridou; Nikolaos Goutas; Christina Tsionou; Kleanthi Dimas; Evi Lianidou; Christos Kroupis (Familial Cancer, 2016)

Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study - Lihui Wang; Pan Zhang; Xiannan Meng; Xiang Chen; Zou Xiang; Xiaoqian Lin; Ye Liu; Weidong Gan; Xiaodong Han; Dongmei Li (Familial Cancer, 2016)

CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case–control study - Sumaira Akhtar; Ishrat Mahjabeen; Zertashia Akram; Mahmood Akhtar Kayani (Familial Cancer, 2016)

Methylation of the miR-126 gene associated with glioma progression - Hongwei Cui; Yongping Mu; Lei Yu; Ya-guang Xi; Rune Matthiesen; Xiulan Su; Wenjie Sun (Familial Cancer, 2016)

Diagnostic values of osteopontin combined with CA125 for ovarian cancer: a meta-analysis - Zhu Lan; Dan Fu; Xiuzhang Yu; Mingrong Xi (Familial Cancer, 2016)

Surveillance using capsule endoscopy is safe in post-colectomy patients with familial adenomatous polyposis: a prospective Japanese study - Minori Matsumoto; Takeshi Nakajima; Yasuo Kakugawa; Taku Sakamoto; Shiko Kuribayashi; Yosuke Otake; Takahisa Matsuda; Yukihide Kanemitsu; Hirokazu Taniguchi; Yutaka Saito (Familial Cancer, 2016)

Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary - Janos Papp; Marietta Eva Kovacs; Zoltan Matrai; Enikő Orosz; Miklós Kásler; Anne-Lise Børresen-Dale; Edith Olah (Familial Cancer, 2016)

Genetic testing for Lynch syndrome: family communication and motivation - Celine H. M. Leenen; Mariska den Heijer; Conny van der Meer; Ernst J. Kuipers; Monique E. van Leerdam; Anja Wagner (Familial Cancer, 2016)

Germline TERT promoter mutations are rare in familial melanoma - Mark Harland; Mia Petljak; Carla Daniela Robles-Espinoza; Zhihao Ding; Nelleke A. Gruis; Remco van Doorn; Karen A. Pooley; Alison M. Dunning; Lauren G. Aoude; Karin A. W. Wadt; Anne-Marie Gerdes; Kevin M. Brown; et al. (Familial Cancer, 2016)

Association between the FTOrs8050136 polymorphism and cancer risk: a meta-analysis - Jian Zhao; Xiaoyi Huang; Mingyuan Yang; Ming Li; Jianming Zheng (Familial Cancer, 2016)

Aortopulmonary window parathyroid gland causing primary hyperparathyroidism in men type 1 syndrome - Francesco Tonelli; Carlo Biagini; Francesco Giudici; Federica Cioppi; Maria Luisa Brandi (Familial Cancer, 2016)

First report of somatic mosaicism for mutations in STK11 in four patients with Peutz–Jeghers syndrome - Victoria McKay; Diane Cairns; David Gokhale; Roger Mountford; Lynn Greenhalgh (Familial Cancer, 2016)

Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer? - Bar Chikman; Tima Davidson; Hasan Kais; Igor Jeroukhimov; Ari Leshno; Judith Sandbank; Ariel Halevy; Ron Lavy (Familial Cancer, 2016)

Screening of HELQ in breast and ovarian cancer families - Liisa M. Pelttari; Laura Kinnunen; Johanna I. Kiiski; Sofia Khan; Carl Blomqvist; Kristiina Aittomäki; Heli Nevanlinna (Familial Cancer, 2016)

Birt–Hogg–Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas - Ernst Näf; Dominik Laubscher; Helmut Hopfer; Markus Streit; Gabor Matyas (Familial Cancer, 2016)
Germline mutation of the FLCN gene causes Birt–Hogg–Dubé syndrome (BHD), a rare autosomal dominant condition characterized by skin fibrofolliculomas, lung cysts, spontaneous pneumothorax and renal tumours. We identified a hitherto unreported pathogenic FLCN frameshift deletion c.563delT (p.Phe188Serfs*35) in a family of a 46-year-old woman presented with macrohematuria due to bilateral chromophobe renal carcinomas. A heritable renal cancer was suspected due to the bilaterality of the tumour and as the father of this woman had suffered from renal cancer. Initially, however, BHD was overlooked by the medical team despite the highly suggestive clinical presentation. We assume that BHD is underdiagnosed, at least partially, due to low awareness of this variable condition and to insufficient use of appropriate genetic testing. Our study indicates that BHD and FLCN testing should be routinely considered in patients with positive family or personal history of renal tumours. In addition, we demonstrate how patients and their families can play a driving role in initiating genetic diagnosis, presymptomatic testing of at-risk relatives, targeted disease management, and genetic counselling of rare diseases such as BHD.

Rhabdoid tumor predisposition syndrome caused by SMARCB1 constitutional deletion: prenatal detection of new case of recurrence in siblings due to gonadal mosaicism - Laura Gigante; Irene Paganini; Marina Frontali; Serena Ciabattoni; Federica Carla Sangiuolo; Laura Papi (Familial Cancer, 2016)

The knowledge value-chain of genetic counseling for breast cancer: an empirical assessment of prediction and communication processes - Nabil Amara; Jolyane Blouin-Bougie; Jalila Jbilou; Norrin Halilem; Jacques Simard; Réjean Landry (Familial Cancer, 2016)

Association of APC I1307K and E1317Q polymorphisms with colorectal cancer among Egyptian subjects - Camelia Abdel-Malak; Hossam Darwish; Afaf Elsaid; Fatma El-Tarapely; Rami Elshazli (Familial Cancer, 2016)

The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer - Sofia Maia; Marta Cardoso; Paula Paulo; Manuela Pinheiro; Pedro Pinto; Catarina Santos; Carla Pinto; Ana Peixoto; Rui Henrique; Manuel R. Teixeira (Familial Cancer, 2016)

Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry - Kris Ann P. Schultz; Anne Harris; Yoav Messinger; Susan Sencer; Shari Baldinger; Louis P. Dehner; D. Ashley Hill (Familial Cancer, 2016)

Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients - Daniel Robert Quast; Ralph Schneider; Emanuel Burdzik; Steffen Hoppe; Gabriela Möslein (Familial Cancer, 2016)

Incidental diagnosis of HLRCC following investigation for Asperger Syndrome: actionable and actioned - Bich-Thu Duong; Ravi Savarirayan; Ingrid Winship (Familial Cancer, 2016)

Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives - Junyi Wang; Bin Zhang; Wensheng Liu; Yongxia Zhang; Xuebing Di; Yanmei Yang; Dangui Yan (Familial Cancer, 2016)

The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy - Jessica E. van der Aa; Jacob P. Hoogendam; Els S. F. Butter; Margreet G. E. M. Ausems; René H. M. Verheijen; Ronald P. Zweemer (Familial Cancer, 2015)

POLE mutations in families predisposed to cutaneous melanoma - Lauren G. Aoude; Ellen Heitzer; Peter Johansson; Michael Gartside; Karin Wadt; Antonia L. Pritchard; Jane M. Palmer; Judith Symmons; Anne-Marie Gerdes; Grant W. Montgomery; Nicholas G. Martin; Ian Tomlinson; et al. (Familial Cancer, 2015)

Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis - N. N. Basu; S. Ingham; J. Hodson; F. Lalloo; M. Bulman; A. Howell; D. G. Evans (Familial Cancer, 2015)

Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene - Aung Ko Win; Jeanette C. Reece; Daniel D. Buchanan; Mark Clendenning; Joanne P. Young; Sean P. Cleary; Hyeja Kim; Michelle Cotterchio; James G. Dowty; Robert J. MacInnis; Katherine M. Tucker; Ingrid M. Winship; et al. (Familial Cancer, 2015)

Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK - Dhivya Chandrasekaran; Usha Menon; Gareth Evans; Robin Crawford; Ertan Saridogan; Chris Jacobs; Marc Tischkowitz; Elly Brockbank; Jatinder Kalsi; Davor Jurkovic; Ranjit Manchanda (Familial Cancer, 2015)

Metastatic sympathetic paraganglioma in a patient with loss of the SDHC gene - Thereasa Rich; Michelle Jackson; Alejandro Roman-Gonzalez; Komal Shah; Gilbert J. Cote; Camilo Jimenez (Familial Cancer, 2015)

Massive gastric polyposis associated with a germline SMAD4 gene mutation - Eline Soer; Wouter H. de Vos tot Nederveen Cappel; Marjolijn J. L. Ligtenberg; Freek Moll; Robert G. Pierik; Juda Vecht; Hans F. A. Vasen; Antoine Flierman (Familial Cancer, 2015)

Challenges to clinical utilization of hereditary cancer gene panel testing: perspectives from the front lines - Rebecca K. Marcus; Jennifer L. Geurts; Jessica A. Grzybowski; Kiran K. Turaga; T. Clark Gamblin; Kimberly A. Strong; Fabian M. Johnston (Familial Cancer, 2015)

High accuracy of family history of melanoma in Danish melanoma cases - Karin A. W. Wadt; Krzysztof T. Drzewiecki; Anne-Marie Gerdes (Familial Cancer, 2015)

BRCA1 gene variant p.P142H associated with male breast cancer: a two-generation genealogic study and literature review - Claudio Spinelli; Silvia Strambi; Lorenzo Piccini; Leonardo Rossi; Paolo Aretini; Adelaide Caligo (Familial Cancer, 2015)

Supporting families with Cancer: A patient centred survivorship model of care - Emily Victoria Craft; Caron Billington; Rory O’Sullivan; Wendy Watson; Nicola Suter-Giorgini; Joanne Singletary; Elizabeth King; Matthew Perfirgines; Annette Cashmore; Julian Barwell (Familial Cancer, 2015)

Coexistence of paraganglioma/pheochromocytoma and papillary thyroid carcinoma: a four-case series analysis - Maria João Bugalho; Ana Luísa Silva; Rita Domingues (Familial Cancer, 2015)

Follicular variant of papillary thyroid cancer in Alström syndrome - M. Papadakis; A. Meyer; F. Schuster; N. Weyerbrock; C. Corinth; C. Dotzenrath (Familial Cancer, 2015)

BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study - Inmaculada de Juan; Sarai Palanca; Asunción Domenech; Lidia Feliubadaló; Ángel Segura; Ana Osorio; Isabel Chirivella; Miguel de la Hoya; Ana Beatriz Sánchez; Mar Infante; Isabel Tena; Orland Díez; et al. (Familial Cancer, 2015)

A functional HOTAIR rs920778 polymorphism does not contributes to gastric cancer in a Turkish population: a case–control study - Süleyman Bayram; Yakup Ülger; Ahmet Taner Sümbül; Berrin Yalınbaş Kaya; Ahmet Rencüzoğulları; Ahmet Genç; Yusuf Sevgiler; Onur Bozkurt; Eyyüp Rencüzoğulları (Familial Cancer, 2015)

Psychological distress related to BRCA testing in ovarian cancer patients - Merete Bjørnslett; Alv A. Dahl; Øystein Sørebø; Anne Dørum (Familial Cancer, 2015)

Prevalence and detection of psychosocial problems in cancer genetic counseling - W. Eijzenga; E. M. A. Bleiker; D. E. E. Hahn; L. E. Van der Kolk; G. N. Sidharta; N. K. Aaronson (Familial Cancer, 2015)

Survival in familial colorectal cancer: a Danish cohort study - Charlotte Kvist Lautrup; Ellen M. Mikkelsen; Timothy L. Lash; Niels Katballe; Lone Sunde (Familial Cancer, 2015)

Childhood cancers in families with and without Lynch syndrome - John A. Heath; Jeanette C. Reece; Daniel D. Buchanan; Graham Casey; Carol A. Durno; Steven Gallinger; Robert W. Haile; Polly A. Newcomb; John D. Potter; Stephen N. Thibodeau; Loïc Le Marchand; Noralane M. Lindor; et al. (Familial Cancer, 2015)

Genotype–phenotype analysis of von Hippel–Lindau syndrome in fifteen Indian families - Narendranath Vikkath; Sindhu Valiyaveedan; Sheela Nampoothiri; Natasha Radhakrishnan; Gopal S. Pillai; Vasantha Nair; Ginil Kumar Pooleri; Georgie Mathew; Krishnakumar N. Menon; Prasanth S. Ariyannur; Ashok B. Pillai (Familial Cancer, 2015)

Birt–Hogg–Dubé syndrome and intracranial vascular pathologies - Rahul Kapoor; Alexander I. Evins; Diala Steitieh; Antonio Bernardo; Philip E. Stieg (Familial Cancer, 2015)

3′-UTR poly(T/U) repeat of EWSR1 is altered in microsatellite unstable colorectal cancer with nearly perfect sensitivity - Johanna Kondelin; Sari Tuupanen; Alexandra E. Gylfe; Mervi Aavikko; Laura Renkonen-Sinisalo; Heikki Järvinen; Jan Böhm; Jukka-Pekka Mecklin; Claus L. Andersen; Pia Vahteristo; Esa Pitkänen; Lauri A. Aaltonen (Familial Cancer, 2015)

Zebrafish xenotransplantation as a tool for in vivo cancer study - Beibei Zhang; Chao Xuan; Yunxi Ji; Weiming Zhang; Daogang Wang (Familial Cancer, 2015)

A novel POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine - Maren F. Hansen; Jostein Johansen; Inga Bjørnevoll; Anna E. Sylvander; Kristin S. Steinsbekk; Pål Sætrom; Arne K. Sandvik; Finn Drabløs; Wenche Sjursen (Familial Cancer, 2015)

Specific Alu elements involved in a significant percentage of copy number variations of the STK11 gene in patients with Peutz–Jeghers syndrome - Pawel Borun; Marina De Rosa; Boguslaw Nedoszytko; Jaroslaw Walkowiak; Andrzej Plawski (Familial Cancer, 2015)

Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study - Yakir Segev; Barry Rosen; Jan Lubinski; Jacek Gronwald; Henry T. Lynch; Pal Moller; Charmaine Kim-Sing; Parviz Ghadirian; Beth Karlan; Charis Eng; Dawna Gilchrist; Susan L. Neuhausen; et al. (Familial Cancer, 2015)

Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews - Guy Rosner; Dani Bercovich; Yael Etzion Daniel; Hana Strul; Naomi Fliss-Isakov; Meirav Ben-Yehoiada; Erwin Santo; Zamir Halpern; Revital Kariv (Familial Cancer, 2015)

Implementing a telephone based peer support intervention for women with a BRCA1/2 mutation - Ashley Farrelly; Victoria White; Mary-Anne Young; Michael Jefford; Sandra Ieropoli; Jessica Duffy; Ingrid Winship; Bettina Meiser (Familial Cancer, 2015)

Germline mutations predisposing to non-small cell lung cancer - Gerald H. Clamon; Aaron D. Bossler; Taher Abu Hejleh; Muhammad Furqan (Familial Cancer, 2015)

Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer - F. G. J. Kallenberg; J. E. G. IJspeert; P. M. M. Bossuyt; C. M. Aalfs; E. Dekker (Familial Cancer, 2015)

Clinical characterization and mutation spectrum in Caribbean Hispanic families with Lynch syndrome - Marcia Cruz-Correa; Yaritza Diaz-Algorri; Julyann Pérez-Mayoral; Wasilah Suleiman-Suleiman; Maria del Mar Gonzalez-Pons; Carlos Bertrán; Nicolás Casellas; Natalia Rodríguez; Sherly Pardo; Keyla Rivera; Rafael Mosquera; Segundo Rodriguez-Quilichini (Familial Cancer, 2015)

Pitfalls in the diagnosis of biallelic PMS2 mutations - Marina Antelo; Daniela Milito; Jennifer Rhees; Enrique Roca; Miguel Barugel; Miriam Cuatrecasas; Leticia Moreira; Maria Liz Leoz; Sabela Carballal; Teresa Ocaña; Maria Pellisé; Antoni Castells; et al. (Familial Cancer, 2015)

Genetic screening in patients with Retinoblastoma in Israel - Michal Sagi; Avishag Frenkel; Avital Eilat; Naomi Weinberg; Shahar Frenkel; Jacob Pe’er; Dvorah Abeliovich; Israela Lerer (Familial Cancer, 2015)

The analysis of a large Danish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 11q24 - Laura Aviaja Rudkjøbing; Hans Eiberg; Hanne Birte Mikkelsen; Marie Louise Mølgaard Binderup; Marie Luise Bisgaard (Familial Cancer, 2015)

The importance of proper bioinformatics analysis and clinical interpretation of tumor genomic profiling: a case study of undifferentiated sarcoma and a constitutional pathogenic BRCA2 mutation and an MLH1 variant of uncertain significance - Elizabeth Varga; Elizabeth C. Chao; Nicholas D. Yeager (Familial Cancer, 2015)

Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation - Haeyoung Kim; Dae-Yeon Cho; Doo Ho Choi; Gee Hue Jung; Inkyung Shin; Won Park; Seung Jae Huh; Sung-Won Kim; Sue K. Park; Jong Won Lee; Seok Jin Nam; Jeong Eon Lee; et al. (Familial Cancer, 2015)

Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study - M. R. Wevers; M. K. Schmidt; E. G. Engelhardt; S. Verhoef; M. J. Hooning; M. Kriege; C. Seynaeve; M. Collée; C. J. van Asperen; R. A. E. M. Tollenaar; L. B. Koppert; A. J. Witkamp; et al. (Familial Cancer, 2015)

Polymorphisms of the XRCC1 gene and breast cancer risk in the Mexican population - Nelly M. Macías-Gómez; Valeria Peralta-Leal; Juan Pablo Meza-Espinoza; Melva Gutiérrez-Angulo; Jorge Durán-González; Juan Manuel Ramírez-González; Alejandra Gaspar-Del Toro; Adolfo Norberto-Rodríguez; Evelia Leal-Ugarte (Familial Cancer, 2015)

Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation - Maria Teresa Vietri; Gemma Caliendo; Concetta Schiano; Amelia Casamassimi; Anna Maria Molinari; Claudio Napoli; Michele Cioffi (Familial Cancer, 2015)

International society for gastrointestinal hereditary tumours—InSiGHT (Familial Cancer, 2015)